School of Medicine
Showing 501-600 of 855 Results
-
Catherine Blish
Frances Krauskopf Conley Professor
Current Research and Scholarly InterestsThe major goal of our research is to gain insight into the prevention and control of HIV and other viral pathogens by studying the interplay between the virus and the host immune response. We investigate the role of various arms of the immune response, but with a particular focus on NK cells. We hope to gain additional insights into control of infectious diseases by studying how pregnancy modulates immune responses.
-
Daniel Bloch
Professor (Research) of Biomedical Data Science (BDS), Emeritus
BioI received my PhD. in Mathematical Statistics in 1967. I joined the research community at the Stanford University School of Medicine, Division of Immunology & Rheumatology, in 1984 as head statistician directing the biostatistics consulting and analytic support of the Arthritis Rheumatism Aging Medical Information System (ARAMIS) and Multipurpose Arthritis Center (MAC) grant-related research programs. In 1993 I was appointed Associate Professor with a joint appointment in the Departments of Medicine and of Health Research & Policy, and am currently Professor of Biostatistics at Stanford University, emeritus since 2007. My contributions to the statistics literature span numerous fields, including methods of sample size estimation, efficiency and bias of estimators, research methods for kappa statistics, non-parametric classification methods and methods of assessing multi-parameter endpoints. I have over 200 peer-reviewed publications. I have been directly involved with the development of numerous criteria rules for classification of diseases and with establishing guidelines for clinical trial research and in proposing responder criteria for osteoarthritis drugs. Since 1987, I have been a consultant on an ad hoc basis to pharmaceutical and biotechnical firms, including both start-up and established companies. I have extensive experience with devices, drugs and biologics and have participated in all aspects of applying statistics to implement investigational plans; e.g.: for protocol development, design of trials, database design. I’ve been a member of the FDA Statistical Advisors Panel, the statistical member on numerous data safety monitoring boards, and frequently represent companies at meetings with the FDA
-
Barbara Block
Charles and Elizabeth Prothro Professor of Marine Sciences, Professor of Oceans and Senior Fellow at the Woods Institute for the Environment
Current Research and Scholarly InterestsThermal physiology, open ocean predators, ecological physiology and tuna biology
-
Andra Leah Blomkalns
Redlich Family Professor
Current Research and Scholarly InterestsDr. Andra Blomkalns is an innovation advocate who believes the best patient-centered programs depend upon clinical practice innovation, continuous data-driven improvement, and interdisciplinary collaboration. Dr. Blomkalns has a long-standing history of scholarship and publication on cardiovascular emergencies, point-of-care testing, innate immunity, and obesity. She has authored or contributed to more than 14 chapters and more than 40 journal articles in peer-reviewed publications on topics influential to administration and organization, clinical best practices, and scientific exploration. Additionally, her grant portfolio diversity reflects her multi-pronged, collaborative approach, and includes institutional, investigator-initiated industry, and federal funding.
-
Daniel Michael Blonigen
Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Blonigen is a Research Career Scientist and an Associate Director at the Center for Innovation to Implementation (Ci2i), VA Palo Alto Health Care System. He is also an Affiliate Investigator with the VA National Center for Homelessness Among Veterans, and an Associate Professor in the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine. He received his doctorate in clinical psychology from the University of Minnesota and is a former VA Career Development Awardee. He is licensed as a clinical psychologist in the State of California.
Dr. Blonigen’s research mission is to identify and develop innovations to increase access and engagement in substance use and mental health care for vulnerable populations. In particular, he is interested in testing the effectiveness and implementation potential of mobile health and peer-based interventions for justice-involved and homeless veterans. He is currently leading or co-leading multisite trials of behavioral interventions for justice-involved and homeless veterans. He is also funded by VA Health Systems Research to tailor smartphone applications for self-management of unhealthy drinking for veteran primary care patients and use of peer specialists to increase patient engagement with these apps.
In addition to research, Dr. Blonigen is actively involved in mentoring and teaching VA research fellows and Stanford University residents. These roles include serving as a faculty mentor for the Stanford Forensic Psychiatry Fellowship Program and the Ci2i VA Palo Alto Training Program. He is a member of several VA management and oversight committees and has served as a grant reviewer for national and international funders. He is an invited speaker at national conferences and cyberseminars devoted to substance use and mental health research, and he holds editorial positions for leading addiction, personality, and assessment journals. -
Gordon Bloom
Lecturer, Medicine - Primary Care and Population Health
BioGordon founded the Social Entrepreneurship Collaboratory (SE Labs) at Stanford, Harvard and Princeton. He teaches about the design, development and leadership of innovative social impact ventures in global health and environmental sustainability.
At Stanford, Gordon is director of the Social Entrepreneurship and Innovation Lab (SE Lab)- Human & Planetary Health and is a faculty fellow of the Center for Innovation in Global Health. He is a Lecturer in the School of Medicine, Division of Primary Care and Population Health/Dept. of Medicine, and an advisor in the Distinguished Careers Institute (DCI), and the Knight-Hennessy Scholars Program, and cofounder of the Stanford Sustainable Societies Lab.
At Harvard, Gordon taught jointly on the faculties of the Harvard T. H. Chan School of Public Health (Health Policy & Management) and the Harvard Kennedy School (Management, Leadership & Decision Sciences) and served as an Expert-in-Residence (EiR) at the Harvard Innovation Lab (i-Lab), and affiliated faculty at the Center for Primary Care, Harvard Medical School (HMS). He was faculty director of the Social Entrepreneurship and Innovation Lab (SE Lab) for US & Global Health, an incubator course taught in a new interdisciplinary, collaborative model based at the i-Lab. He has also served as an Entrepreneur-in-Residence (2013-2014) at Harvard Business School in the Rock Center for Entrepreneurship, on the Faculty of Arts & Sciences in the Sociology Department, at the Harvard Kennedy School, on the Leadership & Management faculty, and as a principal of the Hauser Center for Non-Profit Organizations (2004-2007). Gordon served as one of the founding faculty of the $10 million Reynolds Fellows Program in Social Entrepreneurship, a Center for Public Leadership and Harvard President’s interdisciplinary fellowship initiative that paid full tuition and stipend for graduate students from the Harvard Kennedy School, School of Public Health and Graduate School of Education.
At Princeton, Gordon served as Dean’s Visiting Professor in Entrepreneurship in 2009-2010. Working together with the School of Engineering & Applied Science, the [Woodrow Wilson] School of Public & International Affairs, and the Faculty of Arts & Sciences, he launched a new set of programs and prizes in social innovation and entrepreneurship in collaboration with students, faculty and alumni.
At Stanford in 2001-2002, Gordon created the SE Lab, a Silicon Valley and technology–influenced, interdisciplinary incubator for social impact ventures and global problem solving. Gordon taught on the Public Policy Program and Urban Studies Program faculties (School of Humanities & Sciences) and served as a faculty affiliate at the Center for Social Innovation at Stanford Graduate School of Business, and a Program Officer at Stanford’s Freeman Spogli Institute for International Studies.
Many of the talented students and fellows in Gordon’s SE Labs have won the top awards of prestigious idea and business plan competitions, including those at Stanford, Harvard, Princeton and MIT.
Gordon is a co-author in the edited volume Frontiers in Social Innovation (N. Malhotra, ed., Harvard Business Review Press, 2022) and Social Entrepreneurship: New Models of Sustainable Social Change (A. Nicholls, ed., Oxford University Press, 2006/2008) and served as a founding member of the Oxford/Ashoka led University Network for Social Entrepreneurship. His interest in entrepreneurship is informed by work in both the private and nonprofit sectors in the U.S. (New York, Cambridge, Palo Alto), Europe (London, Paris) and Asia (Hong Kong), as CEO of a medical technology company (EDAP Technomed, USA) and in international strategy consulting (Bain & Co. Ltd.).
Gordon is married to Sara Singer- they on occasion teach together at Stanford, have a daughter Audrey and son Jason, and live in the Frenchman's Hill residential section of campus. -
Zaeda Blotner
Immigrant Child Health Program Administrator, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordImmigrant Child Health Program Administrator
-
Yair Blumenfeld, MD
Professor of Obstetrics and Gynecology (Maternal Fetal Medicine)
Current Research and Scholarly Interestsprenatal diagnosis, genetics, clinical obstetrics
-
Mark S. Blumenkranz, MD, MMS
H. J. Smead Professor of Ophthalmology, Emeritus
Current Research and Scholarly InterestsClinical Interest and Research
My primary areas of interest are in the diagnosis, medical and surgical treatment of vitreal retinal diseases. These principally include age-related macular degeneration and other diseases of the macula, and tractional syndromes, diabetic retinopathy, and complex forms of retinal detachment. I have been interested in the development of novel technology to diagnose and treat these diseases, including new forms of imaging, laser delivery systems, other microsurgical tools, and new drugs and drug delivery systems that inhibit new blood vessel growth, scarring and intraocular inflammation. I have been actively involved in translational research in the laboratory as well as technology transfer associated with that research for a variety of new therapies that have received FDA clearance and been introduced into clinical practice over the past 30 years.
Administrative and Community Service
I have served on the Board of Directors of a variety of voluntary education and service organizations, including the Corporation of Brown University, multiple scientific advisory boards and various philanthropic and research organizations. -
Paul D. Blumenthal, MD, MPH
Professor of Obstetrics and Gynecology (Gynecology-Family Planning) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsImproving Access to Family Planning Services in Low Resource Settings:
Through a collaboration with Population Services International, the Stanford Program for International Reproductive Education and Services (SPIRES) provides technical direction in a program designed to improve access to and uptake of family planning, particularly Long Acting Reversible Contraception (LARC) such as IUDs and implants, in 14 developing countries globally. The first year saw insertion of over 280,000 IUDs. -
Fernando E Boada
Professor of Radiology (Radiological Sciences Laboratory)
BioFernando Boada is a Professor of Radiology and Associate Chair for Basic Science Translational Research at Stanford University Medical School. [1] He joined Stanford in 2021 after being Professor of Radiology, Psychiatry and Neurosurgery at New York University Medical School and the Director of the Center for Advanced Imaging Innovation and Research. [1] Prior to joining NYU in 2012, Dr. Boada directed the MR Research Center (MRRC) at the University of Pittsburgh for ten years. [1] His research efforts have been focused on the development of novel MRI techniques for addressing open neuroimaging questions in a translational setting.
-
Christina Bodurow
Affiliate, Medicine - Med/Gastroenterology and Hepatology
BioChris has a proven record of accomplishment delivering results to pharmaceutical and scientific organizations, including 33 years of management experience at Eli Lilly and Company, within Lilly Research Laboratories (LRL), 3.5 years in a global leadership role at IQVIA, and now as Deputy Director and COO of a significant NIH/NIAID research grant at Stanford University Medical School.
Over the years, Chris has served as a leader of multiple global teams in drug development and R&D Operations, representing her organizations in multiple external settings, including scientific, academic, drug development and R&D Operations forums.
In, December 2017, Chris retired from Lilly as Sr. Director, External Sourcing, leading an enterprise-wide R&D operations group that partnered with LRL functions to assess, on-board, and govern third party organizations across the entire drug development value chain, from pre-clinical, through clinical, regulatory, safety, health outcomes, product and device development, and diagnostics. The division consolidated both corporate and external requirements to deliver high-quality, risk-based, third party governance, oversight and alliance management for the LRL Development organization.
In February 2019, Chris joined IQVIA as the Vice-President of Strategy & Operations for DSSR, and subsequently moved in the role of Vice-President, Global Regulatory Affairs.
Specialties: Pharmaceutical Development, R&D Operations, Molecule Submission/Approval/Launch, Product Lifecycle Planning and Development, R&D Business Systems design and delivery. Third Party Management, Women's Leadership Development. -
Alexandria Boehm
Richard and Rhoda Goldman Professor of Environmental Studies, Professor of Oceans and Senior Fellow at the Woods Institute for the Environment
BioI am interested in pathogens in the environment including their sources, fate, and transport in natural and engineered systems. I am interested in understanding of how pathogens are transmitted to humans through contact with water, feces, and contaminated surfaces. My research is focused on key problems in both developed and developing countries with the overarching goal of designing and testing novel interventions and technologies for reducing the burden of disease.
I am also interested broadly in coastal water quality where my work addresses the sources, transformation, transport, and ecology of biocolloids - specifically fecal indicator organisms, DNA, pathogens, and phytoplankton - as well as sources and fate of nitrogen. This knowledge is crucial to formulating new management policies and engineering practices that protect human and ecosystem health at the coastal margins. -
Alistair Boettiger
Associate Professor of Developmental Biology
Current Research and Scholarly InterestsMy lab focuses on investigating the role of three-dimensional genome organization in regulating gene expression and in shaping cell fate specification during development. We pursue this with advanced single-molecule imaging and transgenics.
-
Raya Bogdanova
Temporary Non-exempt, Psych/General Psychiatry and Psychology (Adult)
BioRaya Bogdanova joins the BRIDGE Lab as a Fulbright visiting student researcher from KU Leuven, where she is completing her Master of Medicine degree. With a long-standing interest in neurocognitive, developmental, and degenerative disorders, she has contributed to research in Alzheimer’s disease, Multiple Sclerosis, and gestational diabetes. Her current work focuses on ADHD-related brain signatures in children with RASopathies. Passionate about student wellbeing, Raya also lead the ADHD peer support network at KU Leuven, bridging her clinical interests with community engagement. Outside the lab, she enjoys swimming, hiking, and exploring art museums in new cities.
-
Matthew Bogyo
Professor of Pathology and of Microbiology and Immunology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur lab uses chemical, biochemical, and cell biological methods to study protease function in human disease. Projects include:
1) Design and synthesis of novel chemical probes for serine and cysteine hydrolases.
2) Understanding the role of hydrolases in bacterial pathogenesis and the human parasites, Plasmodium falciparum and Toxoplasma gondii.
3) Defining the specific functional roles of proteases during the process of tumorogenesis.
4) In vivo imaging of protease activity -
Bryan Bohman
Clinical Professor, Medicine - Primary Care and Population Health
BioBryan Bohman is Associate Chief Medical Officer for Workforce Health and Wellness. Additional roles include Clinical Professor of Medicine and of Anesthesiology, Co-Director of the Clinical Effectiveness Leadership Training (CELT) program and Senior Advisor to the WellMD Center.
Bryan trained at Stanford in internal medicine and anesthesiology. After two decades of clinical practice in community-based anesthesiology, he served as SHC's first elected Chief of Staff from 2008-2011.
As Chief of Staff, Dr. Bohman established Stanford’s wellness committee and subsequently shepherded the founding of its WellMD Center in 2015, serving as the Center’s interim Director until 2017. The Center’s aim is to advance faculty, trainee and care team wellbeing across Stanford Medicine while also serving as an international leader of scholarship in occupational wellbeing. Bryan also led the establishment in 2014 of the CELT program, which continues to serve as a driver of clinical quality improvement across Stanford Medicine.
Dr. Bohman’s primary areas of interest include occupational wellbeing, process improvement, and the reciprocal influences between quality improvement, healthcare system performance, and the occupational wellbeing of healthcare personnel. -
Brian Boitnott
Ph.D. Student in Biomedical Physics, admitted Autumn 2023
BioI am currently a Biomedical Physics PhD candidate in the Department of Radiology. In the two years prior to Stanford, I was at MIT Lincoln Laboratory, where I worked on airborne remote sensing systems and was on the core team developing a laser-ultrasound system for medical imaging.
My interests revolve around health technology and perception. I started in neuroscience, studying attention and cognitive control, and now work on designing systems and algorithms for sensing and processing biomedical signals. My broader interests are at the intersection between emerging technology innovation, translation, and long-term innovation strategy. -
MacKenzie Bolen
Postdoctoral Scholar, Neurology and Neurological Sciences
BioDr. MacKenzie “Mack” Bolen’s defining research passion is to leverage accessible and modifiable lifestyle factors to mitigate neurodegenerative risk. During her undergraduate education at Austin College in Texas, she began pursuing her interest in neurodegeneration by conducting research focused on the neuroprotective benefits of the ketogenic diet. This work evolved into an honors thesis investigating markers of inflammation in saliva from contact sport athletes and culminated in a TEDx talk on sports-related brain injuries. These experiences cemented her desire to understand the minutiae of the brain and catalyzed her decision to pursue a Ph.D. in Neuroscience at the University of Florida (UF). During Mack’s training under Dr. MG. Tansey at UF, her dissertation work generated global collaborations centered on a multiomic approach that leverages machine learning to identify peripheral biomarkers and novel therapeutic targets to slow the onset or progression of Parkinson’s disease. A hallmark of Mack’s career has been participating in collaborative team science and mentorship of the next generation of scientists, where she has consistently mentored advanced and budding scientists within the Gainesville community and collaborated on several manuscripts from labs across the nation. In addition to her scholarly work, she regularly volunteered at the UF Neuromedicine Intensive Care Unit (Neuro ICU) while pursuing her Ph.D. to better understand the clinical perspective of neurodegeneration.
By blending her Ph.D. training and experiences in the Neuro ICU, Mack hopes to actively improve the treatment of individuals living with neurodegeneration and continue to push the frontier of medicine as a postdoctoral scholar in Neurology and Neurological Sciences at Stanford. Now under the mentorship of Dr. K. Poston, Mack will continue to access essential training at the intersection of immunology and Parkinson’s disease, via the investigation of the gut-brain axis. As a former collegiate soccer player, Mack loves to pretend to relive her glory days during rec-league on the weekends and can also be found struggling through a Yin yoga class. -
Sam Bollinger
Ph.D. Student in Cancer Biology, admitted Autumn 2021
BioOriginally from State College, Pennsylvania, Sam graduated with honors from Penn State University with a B.S. in Chemistry and a minor in Biology. He subsequently spent three years working at the Lankenau Institute for Medical Research for Dr. Ellen Heber-Katz. Sam hopes to expand the paradigm of cancer research and help to develop novel therapies for cancer and other ailments. He is also interested in optimization of physical and mental performance.
-
Paul Bollyky
Stanford Medicine Professor of Infectious Disease and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsBacteriophages, viruses that infect bacteria, are abundant in the human body. However, their contributions to human health and disease are largely unknown. The Bollyky Lab
studies interactions between phages and both their human and bacterial hosts with the goal of developing innovative strategies to improve human health. -
Anna Maria Bombardieri, MD, PhD, MSc
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsMy research program focuses on the autonomic nervous system as a modifiable determinant of physiological resilience and recovery across acute and chronic disease states. I investigate sympathetic modulation as a therapeutic strategy, examining how regional anesthetic and neuromodulation techniques, including cervical sympathetic and stellate ganglion blocks, influence cerebral perfusion, cardiovascular regulation, neuroimmune interactions, and functional outcomes.
Through the integration of clinical trials, translational human physiology, and advanced physiologic monitoring, my work seeks to elucidate mechanisms of autonomic dysfunction and to develop evidence-based neuromodulation approaches for conditions such as aneurysmal subarachnoid hemorrhage, postural orthostatic tachycardia syndrome (POTS), and post-acute sequelae of COVID-19 (Long COVID). The long-term objective of this research is to advance interdisciplinary models of care and to translate autonomic science into therapeutic strategies that improve long-term patient outcomes. -
Serena Bonaretti
Physical Science Research Scientist, Rad/Musculoskeletal Imaging
BioPlease visit My Personal Site and the JOINT Group Website (Links on the right)
-
Melissa L Bondy
Stanford Medicine Discovery Professor, Professor of Epidemiology and Population Health and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsPrincipal Investigator, Discovery, Biology and Risk of Inherited Variants in Glioma, 1R01CA217105-01A1, NIH/NCI, 05/01/2018-06/30/2022, MPI (Contact PI)
Principal Investigator, Characterizing Germline and Somatic Alterations by Glioma Subtypes and Clinical Outcome, 1R01CA232754-01, 07/01/2019-06/30/2023, MPI (Contact PI)
Co-Leader (Project), SPORE in Brain Cancer, PI – Fred Lang (Sub with MD Anderson), 2 P50CA127001-11, 09/01/2019-08/31/2023
Co-Investigator, Stanford University Cancer Center, PI – Steve Artandi, P30 CA124435, NCI, 09/15/10-05/31/22
Co-Investigator, Ovarian Cancer Survival in African-American Women, PI, Joellen Schildkraut, R01 CA237318-01A1, NIH/NCI, 07/01/2020-06/31/2025 -
C. Andrew Bonham, MD, FACS
Associate Professor of Surgery (Abdominal Transplantation), Emeritus
Current Research and Scholarly InterestsTolerance induction in liver transplantation.
Hepatocyte transplantation. -
Bernardo Bonilauri
Instructor, Cardiovascular Institute
BioDr. Bernardo Bonilauri is a molecular biologist investigating the fundamental mechanisms of protein misfolding, cryptic peptides, and non-canonical codes in human biology and disease. He completed his postdoctoral training at the Stanford Cardiovascular Institute under the mentorship of Dr. Joseph C. Wu, after which he was appointed Instructor. In this role, he continues to develop advanced in vitro disease models to probe molecular and cellular processes underlying human pathology.
His research focuses on Transthyretin Amyloidosis (ATTR) and related protein misfolding disorders, applying multi-omics, structural biology, and stem cell–based platforms to dissect how pathogenic aggregates form and impair cellular function. In parallel, Dr. Bonilauri investigates microproteins encoded by small open reading frames (sORFs), with emphasis on their translation, subcellular localization, and biological functions in human cells. -
Hector Fabio Bonilla
Clinical Professor, Medicine - Infectious Diseases
BioAs a young physician at Louisiana State University, Dr. Bonilla focused on the Clinical Management of HIV/AIDS and HCV, two neglected and stigmatized diseases for which effective therapies were in their infancy. While learning the clinical aspects of the two diseases, Dr. Bonilla saw a need to create and organize a support community to promote understanding and management of the conditions. Subsequently, he went to Summa Health System in Akron, Ohio, and he continued his work where he specialized in HIV/HCV as well as in Infectious Diseases Clinical Practice. In addition to teaching medical residents and students, Dr. Bonilla participated in numerous clinical trials and developed clinical research projects. Furthermore, he led the Infection Renal Transplant Program, HIV and HCV clinics, and he participated in several cooperative studies with Case Western Reserve University. Dr. Bonilla’s interest in academia led him to the University Of Pittsburgh Medical Center where he was an Assistant Professor, Clinician, and Medical Educator in the Department of Medicine in the Division of Infectious Diseases. Due to his interest in cytokines and immunological responses, Dr. Bonilla became a researcher at ImmunoScience Inc., a biotechnology company in California that works to develop a therapeutic HIV vaccine. Dr. Bonilla’s experience of treating HIV/HCV combined with his interest in inflammatory response is the driving force behind his desire to understand ME/CFS. Dr. Bonilla is a strong patient advocate, and he believes in integrated care—care in which physicians communicate and coordinate efforts to deliver the best medical outcome for patients. His ME/CFS patients are his inspiration, and he is committed to continuing research to seek answers to their health challenges.
-
Anna Booman
Member, Maternal & Child Health Research Institute (MCHRI)
BioAnna Booman, PhD, MS is a Postdoctoral Scholar in the Department of Anesthesiology, Perioperative, and Pain Medicine. She conducts perinatal pharmacoepidemiology research to study the safety and effectiveness of medication use during pregnancy, since most pregnant individuals cannot be included in clinical trials. She uses large observational datasets, such as the Merative MarketScan Database, and complex epidemiologic methods in her research.
Dr. Booman received her PhD in Epidemiology from the Oregon Health & Science University School of Public Health, her MS in Computational Biology and Quantitative Genetics from the Harvard T.H. Chan School of Public Health, and her BS in Mathematical Biology (minor: Computer Science) from the College of William & Mary. Her research has spanned many areas of perinatal epidemiology, including a focus on twin children, rare genetic disorders, gestational weight gain, and insurance discontinuity in pregnancy. -
John Boothroyd
Burt and Marion Avery Professor of Immunology, Emeritus
Current Research and Scholarly InterestsUntil its permanent closure in 2025, John Boothroyd's lab focused on the interaction between the protozoan parasite Toxoplasma gondii and its mammalian host. We used a combination of molecular and genetic tools to understand how this obligate intracellular parasite can invade almost any cell it encounters, how it co-opts a host cell once inside and how it evades the immune response to produce a life-long, persistent infection.
-
Alexandra Bor, MD
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Alexandra Bor is a board-certified, fellowship-trained anesthesiologist with Stanford Health Care. She is also a clinical assistant professor in the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine.
Dr. Bor specializes in anesthesia and pain management, with an emphasis on pediatric anesthesiology.
Her research focuses on improving surgical techniques and patient experience during procedures.
Dr. Bor has published her research in several peer-reviewed journals, including Anesthesia & Analgesia, Canadian Journal of Urology, Journal of Cardiothoracic and Vascular Anesthesia, and Urology. She has also contributed chapters to “Anesthesiologist's Manual of Surgical Procedures” and presented to her peers at national meetings.
Dr. Bor is a member of the American Society of Anesthesiologists and the Society for Pediatric Anesthesia. -
Karoline Marie Bornemann
Postdoctoral Scholar, Cardiology
BioKaroline-Marie Bornemann, PhD, is a biomedical engineer interested in cardiovascular flows, specifically the computational modeling of heart valves using fluid-structure interaction simulations. Her current postdoctoral research in the Marsden lab at Stanford University focuses on the simulation of congenital valve pathologies and valve repair in pediatrics working with Alexander D. Kaiser, Alison Marsden and Michael Ma. She obtained her PhD in Biomedical Engineering from the University of Bern where she investigated instability mechanisms leading to laminar-turbulent transition past bioprosthetic aortic valves with Dominik Obrist and Peter Schmid. During her PhD, she performed a secondment at KTH Royal Institute of Technology collaborating with Ardeshir Hanifi and Dan Henningson assessing the stability of flow fields past valve prostheses. Visualizations of her PhD research were showcased in a winning entry of the Gallery of Fluid Motion 2024 and her PhD thesis won the GCB Best PhD Thesis 2024 Award.
-
Mariya Borodyanskaya
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Mariya Borodyanskaya enjoys being part of the Stanford Team at Mills, an interdisciplinary team dedicated to supporting adolescents and their families in navigating the challenges of mental health crisis. She maintains a broad set of interests, including Post Traumatic Stress Disorder, Psychotic Disorders and Juvenile Justice system reform. She also enjoys supervising and teaching the Stanford Child & Adolescent Psychiatry fellows.
-
Amber Noelle Borucki
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Amber Borucki is an anesthesiologist and pain medicine specialist whose focus is chronic pain management in children and adolescents/young adults. She focuses on reducing or managing pain from chronic conditions in children or pain that occurs after surgery. Dr. Borucki completed her medical degree at Rush Medical College in Chicago, IL. She attended anesthesia residency at the University of Chicago. She completed a fellowship in pediatric anesthesiology at Boston Children's Hospital as well as a combined adult/pediatric pain medicine fellowship at Boston Children's Hospital, Brigham Women's Hospital, and Beth Israel Deaconess Medical Center. Dr. Borucki worked for 5 years as a pediatric anesthesiologist and pain medicine specialist at UCSF Benioff Children's Hospital from 8/2017-5/2023. She was the Director of the Pediatric Anesthesia Service at UCSF during this time. Dr. Borucki transitioned to Stanford Medicine Children's Health in May 2023 and her clinical duties include working in the Emeryville satellite pediatric pain clinic, pediatric operating room, and pediatric pain inpatient service. Dr. Borucki is the Director for Pediatric Pain Education at Stanford, and has partnered with the Adult Pain Medicine program at Stanford to develop an exciting new pediatric pain fellowship track spanning Stanford Health Care and Stanford Medicine Children's Health. She will be the program director of of the pediatric component of this track.
Notable accomplishments include developing and co-chairing the UCSF Benioff Transbay Pediatric Pain Management Committee, development of the pediatric establishment of an adolescent/young adult transitional pain clinic, and serving on the Bridge to One Bay project to standardize pain care across all UCSF Benioff Children's Hospital locations. Dr. Borucki also was instrumental in helping UCSF Benioff Children's Hospital obtain ChildKind designation, a prestigious designation for a hospital indicating that it prioritizes pediatric pain care. She also has been instrumental in the development of the new Pediatric Pain Medicine Fellowship Track at Stanford.
Dr. Borucki has recently collaborated with Dr. Lauren Harrison of the Biobehavioral Pediatric Pain laboratory and together they were awarded a Pediatric Anesthesiology & Pain Medicine at Stanford School of Medicine Pilot Award to examine biopsychosocial demographic data around chronic pediatric back pain. Their study (PEDS-Back) is now enrolling patients through the pediatric pain medicine clinic.
Dr. Borucki has been a member of the medical advisory council for the Make a Wish Bay Area chapter for almost 10 years. She is currently serving as the Secretary/Treasurer for the Society for Pediatric Pain Medicine (SPPM) and also served as the program director for the 12th annual SPPM meeting. Dr. Borucki has also served on several committees through the American Society of Anesthesiologists, California Society of Anesthesiologists, and Women Innovators in Pain Medicine national society. Dr. Borucki served as an editorial board member for Paediatric and Neonatal Pain. -
Rupan Bose, MD, MB
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioRupan Bose, MD, MB, is a Cardiologist and Clinical Assistant Professor in the Division of Cardiovascular Medicine at Stanford University. He specializes in Preventive Cardiology, with a particular focus on high-risk populations. His mission is to identify the underlying drivers of cardiovascular risk, and his clinic is focused on taking a data-driven approach to addressing each of those individual risk factors. He is also deeply involved in the intersection of medicine and technology, with a particular focus on leveraging emerging technologies and innovations to improve cardiovascular disease monitoring and outcomes.
Dr. Bose is a local Bay Area native. He completed his Medical Degree from the Keck School of Medicine of USC. He then completed his Residency in Internal Medicine at USC, followed by his Fellowship in Cardiovascular Medicine at Harbor-UCLA. With his interest in medicine and technology, he holds a Masters in Biotechnology (MB) with an emphasis on Bioinformatics from the University of Pennsylvania.
At Stanford, Dr. Bose serves in the Preventive Cardiology clinic and also the Stanford South Asian Translational Heart Initiative (SSATHI) clinic. He also serves as the Medical Director for the Inpatient Cardiology Services and the Medical Director of the Inpatient Cardiology (J7) Unit. Additionally, he serves on the Cardiology Consult service and Inpatient Cardiology service, where he supervises and teaches Fellows, Residents, and Medical Students from the Stanford University School of Medicine. -
Crystal M. Botham, Ph.D.
Director of Grant Writing Academy & Office of Research Development, Pediatrics
Current Role at Stanford• Providing individualized grantsmanship assistance to postdoctoral fellows and faculty
• Editing and critically evaluating grant applications to improve funding potential
• Interpreting sponsor requirements and providing strategic advice
• Identifying a diverse portfolio of funding opportunities
• Designing and facilitating courses to enable postdoctoral fellows to develop competitive Career Development applications
• Developing and presenting at workshops on grant writing and proposal submission
• Coordinating completion of subcontracts and large collaborative projects -
Nawal Maria Boukli
Affiliate, Neurosurgery
BioDr. Nawal Boukli’s research focuses on understanding how cells transition from adaptive to maladaptive stress responses, with a central emphasis on endoplasmic reticulum (ER) stress, unfolded protein response (UPR) signaling, and GRP78 as a master regulator of cell fate and survival. Her work has defined critical mechanistic links between GRP78-driven stress adaptation, metabolic reprogramming, and therapeutic resistance in glioblastoma (GBM), while advancing GRP78 as a translational therapeutic target through antibody-based anti-GRP78 strategies designed to disrupt tumor survival pathways.
Her broader research program integrates molecular biology, quantitative multi-omics, cancer biology, and NeuroHIV to uncover stress-driven mechanisms underlying disease progression. In parallel, her NeuroHIV studies investigate how HIV-1 gp120 induces maladaptive ER stress responses that alter astrocyte–neuron communication, promote synaptic vulnerability, and contribute to neurodegenerative processes. Collectively, her work bridges cancer and neurodegeneration through a unifying framework centered on proteostasis disruption and chronic stress signaling.
In her project at Stanford University, awarded by The NIH Brain Initiative, Dr. Boukli is extending her research program using advanced spatial omics and neurobiology approaches to define astrocyte-specific ER stress domains and map how gp120-driven stress signaling becomes spatially organized within intact neural systems. This work aims to identify spatially resolved therapeutic targets and advance high-impact translational neuroscience studies.
Dr. Boukli is also recognized for her innovative teaching, scientific leadership, and commitment to mentorship. She has mentored more than 32 master’s students, 8 Ph.D. students, and numerous undergraduate trainees, while developing student-centered scientific training and mentoring initiatives. Following her election to the Association of Biomolecular Resource Facilities Executive Board in 2019, she launched the organization’s first annual speed-mentoring initiative in 2020. She additionally serves as a reviewer for the National Institutes of Health Center for Scientific Review, including study sections focused on cancer therapeutics and biomarker development.
Selected Peer-Reviewed Publications:
https://pubmed.ncbi.nlm.nih.gov/?term=nawal+boukli&sort=pubdate -
Donna M. Bouley, DVM, PhD
Professor of Comparative Medicine at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsResearch interests: ocular pathology, host-pathogen interactions in infectious disease, infectious disease in frogs, phenotypic characterization of tg and ko mice, histopathology of minimally-invasive radiological ablation techniques (focused ultrasound, cryoablation).
-
Robert Downey Boutin
Clinical Professor, Radiology
BioDr. Boutin works clinically as a musculoskeletal radiologist interpreting a broad array of diagnostic imaging examinations, most frequently MRI, CT, sonography, and radiography.
The clinical focus for Dr. Boutin is MRI and CT of joints, bones, and muscles, as well as adding value to routine radiology exams by translating advancements from fields of artificial intelligence and imaging informatics. These advancements include enhancing routine imaging exams to help promote physical function, quality of life, and healthspan in our patients. Because the worldwide population of people > 60 years of age is projected to double by 2050, there is a crucial need for improvements in the accurate and efficient management of derangements associated with biological aging, including osteoporosis, sarcopenia, and adiposity.
Dr. Boutin was introduced to orthopaedics at an early age by his father and older brother -- both orthopaedists. After earning undergraduate and graduate degrees at Stanford University, Dr. Boutin completed advanced fellowship training in Musculoskeletal Imaging at the University of California, San Diego, and worked on the faculty at Harvard Medical School. Core professional values include a commitment to outstanding quality, compassion, safety, and integrity.
Dr. Boutin is a leader in musculoskeletal imaging. He is the President of the Society of Academic Bone Radiologists and serves on the Appropriateness Criteria Panel for the American College of Radiology. He is an Assistant Editor at the American Journal of Roentgenology (AJR), and recently served as the Chair of the Musculoskeletal Imaging Program Committee for the largest medical meeting in the world (RSNA).
He is a frequent invited lecturer for continuing medical education courses, such as those at the annual meetings of the Radiological Society of North America, the International Skeletal Society, and the American Roentgen Ray Society. He also lectures regularly at the international Orthopaedic Imaging course in Davos, Switzerland. -
Sierra Bowden
Affiliate, Medicine - Med/Hematology
BioSierra is a 6th year PhD Student at Stanford University in the department of Genetics. In Ami Bhatt's lab, she has worked to characterize the hidden features of bacterial genomes, including small proteins, noncoding RNAs, and mobile genetic elements. In particular, her work has focused on understanding the role of sRNA 84 in Enterococcus faecalis and colonization of the gut microbiome.
Interests: gene regulation; sRNA; microbiome; ESKAPE pathogens; antibiotic resistance; microbe-host or phage-host interactions;
Skills: transcriptomics; microbial genetics; genomics; antibiotic sensitivity testing; biofilm and phenotypic assays;
